These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 11268885)

  • 21. [Beta-receptor blockers and chronic obstructive respiratory tract diseases].
    Wettengel R
    Dtsch Med Wochenschr; 1994 Mar; 119(11):404; author reply 405. PubMed ID: 7755668
    [No Abstract]   [Full Text] [Related]  

  • 22. Beta-agonists, beta-blockers and obstructive airway disease.
    Madalena Esteves M
    Eur Ann Allergy Clin Immunol; 2005 Dec; 37(10):375-9. PubMed ID: 16528900
    [No Abstract]   [Full Text] [Related]  

  • 23. [Use of beta blockers in cardiovascular diseases and bronchial asthma/COPD].
    Glaab T; Weiss T
    Internist (Berl); 2004 Feb; 45(2):221-7. PubMed ID: 14991165
    [TBL] [Abstract][Full Text] [Related]  

  • 24. beta-Blocker therapy in veterans with asthma or chronic obstructive pulmonary disease.
    Barnett MJ; Milavetz G; Kaboli PJ
    Pharmacotherapy; 2005 Nov; 25(11):1550-9. PubMed ID: 16232018
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Drug therapy for asthma.
    Farel RM
    N Engl J Med; 2009 Jun; 360(24):2579; author reply 2579. PubMed ID: 19522049
    [No Abstract]   [Full Text] [Related]  

  • 26. [Interactions of asthma spray-beta blockers].
    Hennemann A
    Med Monatsschr Pharm; 2003 Feb; 26(2):60. PubMed ID: 12619526
    [No Abstract]   [Full Text] [Related]  

  • 27. [Beta-blockers usage in cardio-vascular diseases co-existing with COPD].
    Walczak D; Kowal A; Jankowska R
    Pol Merkur Lekarski; 2012 Dec; 33(198):338-41. PubMed ID: 23437704
    [TBL] [Abstract][Full Text] [Related]  

  • 28. COPD and beta-blockers.
    Segal MS; MacDonnell KF
    Compr Ther; 1982 Sep; 8(9):3-5. PubMed ID: 6128100
    [No Abstract]   [Full Text] [Related]  

  • 29. Adenosine receptor ligands: potential as therapeutic agents in asthma and COPD.
    Fozard JR; Hannon JP
    Pulm Pharmacol Ther; 1999; 12(2):111-4. PubMed ID: 10373392
    [No Abstract]   [Full Text] [Related]  

  • 30. [Beta-adreno-blockers use in combination of cardiovascular and pulmonary diseases].
    Makolkin VI; Ovcharenko SI; Litvinova IV
    Ter Arkh; 2008; 80(8):86-9. PubMed ID: 18807550
    [No Abstract]   [Full Text] [Related]  

  • 31. Beta-blockers are safe in patients with chronic obstructive pulmonary disease, but only with caution.
    Cazzola M; Matera MG
    Am J Respir Crit Care Med; 2008 Oct; 178(7):661-2. PubMed ID: 18796649
    [No Abstract]   [Full Text] [Related]  

  • 32. Getting to the heart of asthma: can "beta blockers" be useful to treat asthma?
    Bond RA; Spina D; Parra S; Page CP
    Pharmacol Ther; 2007 Sep; 115(3):360-74. PubMed ID: 17681610
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Heart and lung disease. Are beta blockers allowed in asthma?].
    MMW Fortschr Med; 2001 May; 143(21):58. PubMed ID: 11420835
    [No Abstract]   [Full Text] [Related]  

  • 34. [Beta-blockers and statins in the context of asthma].
    Pawlak J; Zietkowski Z; Bodzenta-Łukaszyk A
    Postepy Hig Med Dosw (Online); 2009 Dec; 63():634-42. PubMed ID: 20097950
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of beta-adrenoreceptor blockers in combination with beta-stimulators in patients with obstructive lung disease.
    Johnsson G
    Drugs; 1976; 11 SUPPL 1():171-7. PubMed ID: 6250
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The place of long-acting beta 2 adrenergic agonists in the treatment of asthma and chronic obstructive lung disease (COPD)].
    van Schayck CP; Postma DS; Lammers JW
    Ned Tijdschr Geneeskd; 1999 Jan; 143(3):137-40. PubMed ID: 10086126
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Treatment of moderate persistent asthma: inhalation corticosteroids in combination with long acting beta 2-adrenergic agonists (bronchodilators) then with leukotriene receptor antagonists (anti-inflammatory agents); the 'step-3-dilemma'].
    Diamant Z; Dekhuijzen PN
    Ned Tijdschr Geneeskd; 2003 Aug; 147(35):1681-5. PubMed ID: 14513539
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Methodological aspects of the testing of beta-blockers in patients with obstructive lung disease].
    Albrektsen T; Legemidler H
    Tidsskr Nor Laegeforen; 1979 Mar; 99(8):416-9. PubMed ID: 34900
    [No Abstract]   [Full Text] [Related]  

  • 39. Therapeutic options for persistent asthma.
    Holgate ST
    JAMA; 2001 May 23-30; 285(20):2637-9. PubMed ID: 11368739
    [No Abstract]   [Full Text] [Related]  

  • 40. Pharmacological treatment in asthma and COPD.
    Hoshino T; Toda R; Aizawa H
    Allergol Int; 2009 Sep; 58(3):341-6. PubMed ID: 19628978
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.